Immunopotentiation and antitumor effects of a ginsenoside Rg 3-fortified red ginseng preparation in mice bearing H460 lung cancer cells

Environmental Toxicology and Pharmacology

Volumn 31, Issue 3, 2011, Pages 397-405

  Park, Dongsun ^a   Bae, Dae Kwon ^a   Jeon, Jeong Hee ^a   Lee, Jinsoo ^a   Oh, Namgil ^a   Yang, Goeun ^a   Yang, Yun Hui ^a   Kim, Tae Kyun ^a   Song, Jugyeong ^a   Lee, Sun Hee ^a   Song, Byeng Sub ^b   Jeon, Tae Hawn ^b   Kang, Shin Jyung ^b   Joo, Seong Soo ^c   Kim, Seung U ^d   Kim, Yun Bae ^a,d  

^a Chungbuk National University   (South Korea)

^b Joongbu University   (South Korea)

^c Gangneung Wonju National University   (South Korea)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Antitumor activity; Ginsenoside Rg 3 fortified red ginseng preparation; Immunomodulation; Lung cancer (H460)

Indexed keywords

DOXORUBICIN; GINSENOSIDE RG 3 FORTIFIED RED GINSENG PREPARATION; HERBACEOUS AGENT; NITRIC OXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MEGADOSE; GINSENG; HUMAN; HUMAN CELL; IC 50; IMMUNOMODULATION; IMMUNOPOTENTIATION; IN VITRO STUDY; IN VIVO STUDY; LOW DRUG DOSE; LUNG NON SMALL CELL CANCER; LYMPHOCYTE PROLIFERATION; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; SPERMATOZOON; SPLEEN CELL; TESTIS WEIGHT; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT; WEIGHT REDUCTION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BODY WEIGHT; CARBON; CELL LINE, TUMOR; CELL PROLIFERATION; DOXORUBICIN; GINSENOSIDES; HEART; HUMANS; LUNG NEOPLASMS; LYMPHOCYTES; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED ICR; NEOPLASM TRANSPLANTATION; NITRIC OXIDE; ORGAN SIZE; PANAX; PLANT PREPARATIONS; SPLEEN; TESTIS;

MUS; MUS MUSCULUS; PANAX GINSENG;

EID: 79954687741     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2011.01.008     Document Type: Article

References (49)

1. Akao T., Kida H., Kanaoka M., Hattori M., Kobashi K. Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng. J. Pharm. Pharmacol. 1998, 50:1155-1160.
2. Attele A.S., Wu J.A., Yuan C.S. Ginseng pharmacology: multiple constituents and multiple actions. Biochem. Pharmacol. 1999, 58:1685-1693.
3. Aung H.H., Mehendale S.R., Wang C.Z., Xie J.T., McEntee E., Yuan C.S. Cisplatin's tumoricidal effect on human breast carcinoma MCF-7 cells was not attenuated by American ginseng. Cancer Chemother. Pharmacol. 2007, 59:364-374.
4. Banthorpe D.V. Terpenoid. Natural Product 1994, 331-339. Longman Scientific and Technical, Essex. J. Mann (Ed.).
5. Chai H.-Y., Sin J.-S., Kim T.M., Kwon W., Cho Y.M., Choi E.-K., Hwang S.-Y., Kim Y.-B., Kang J.-K. Antitumor activity of K6, an allylthiopyridazine derivative, in Hep-G2 cells-transplanted nude mice. Korean J. Lab. Anim. Sci. 2004, 20:68-75.
6. 1 in dependence on intestinal bacterial hydrolyzing potential and significance of treatment with an active bacterial metabolite. Planta Med. 1998, 64:696-700.
7. Hasegawa H., Sung J.H., Matsumiya S., Uchiyama M. Main ginseng saponin metabolites formed by intestinal bacteria. Planta Med. 1996, 62:453-457.
8. 3 of bombesin-enhanced peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in Wistar rats. Clin. Exp. Metastasis 1997, 15:603-611.
9. Imahie H., Adachi T., Nakagawa Y., Nagasaki T., Yamamura T., Hori M. Effects of adriamycin, an anticancer drug showing testicular toxicity, on fertility in male rats. J. Toxicol. Sci. 1995, 20:183-193.
10. Iwahashi T., Okochi E., Ariyoshi K., Watabe H., Amann E., Mori S., Tsuruo T., Ono K. Specific targeting and killing activities of anti-P-glycoprotein monoclonal antibody MRK16 directed against intrinsically multidrug-resistant human colorectal carcinoma cell lines in the nude mouse model. Cancer Res. 1993, 53:5475-5482.
11. 3 and its role in microglial activation. Biol. Pharm. Bull. 2008, 31:1392-1396.
12. Jun C.D., Choi B.M., Lee S.Y., Kang S.S., Kim H.M., Chung H.T. Nitric oxide inhibits the expression of protein kinase C gene in the murine peritoneal macrophages. Biochem. Biophys. Res. Commun. 1994, 204:105-111.
13. Jung N.P., Jin S.H. Studies on the physiological and biochemical effects of Korean ginseng. Korean J. Ginseng Sci. 1996, 20:431-471.
14. Jung M.Y., Kwon S.K., Moon A. Chemopreventive allylthiopyridazine derivatives induced apoptosis in SK-Hep-1 hepatocarcinoma cells through a caspase-3-dependent mechanism. Eur. J. Cancer 2001, 37:2104-2110.
15. Kang J.-K., Lee Y.-J., No K.-O., Jung E.-Y., Sung J.-H., Kim Y.-B., Nam S.-Y. Ginseng intestinal metabolite-I (GIM-I) reduces doxorubicin toxicity in the mouse testis. Rep. Toxicol. 2002, 5442:1-8.
16. 3 on phorbol ester-induced cyclooxygenase-2 expression, NF-κB activation and tumor promotion. Mutat. Res. 2003, 523-524:75-85.
17. Kim W.Y., Kim J.M., Han S.B., Lee S.K., Kim N.D., Park M.K., Kim C.K., Park J.H. Steaming of ginseng at high temperature enhances biological activity. J. Nat. Prod. 2000, 63:1702-1704.
18. 2 on the proliferation of prostate cancer cells. Arch. Pharm. Res. 2004, 27:429-435.
19. 3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-κB. Eur. J. Pharmacol. 2010, 631:1-9.
20. 3 enhances the susceptibility of colon cancer cells to docetaxel. Arch. Pharm. Res. 2009, 32:755-765.
21. Kitts D.D., Wijewickreme A.N., Hu C. Antioxidant properties of a North American ginseng extract. Mol. Cell. Biochem. 2000, 203:1-10.
22. Klaassen C.D. Casarett & Doull's Toxicology 2001, McGraw-Hill, New York, pp. 45-47. sixth ed.
23. Kowalski R. Studies of selected plant raw materials as alternative sources of triterpenes of oleanolic and ursolic acid types. J. Agric. Food. Chem. 2007, 55:656-662.
24. Langdon S.P., Hendrick H.R., Braakhuis B.J., Pratesi G., Berger D.P., Fodstad O., Frebig H.H., Boven E. Precilinical phase II studies in human xenografts. Ann. Oncol. 1994, 5:415-422.
25. Liu C.X., Xiao P.G. Recent advances on ginseng research in China. J. Ethnopharmacol. 1992, 36:27-38.
26. 3 on lung metastasis of mouse melanoma transfected with ribonuclease inhibitor. Chin. J. Oncol. 2004, 26:722-725.
27. Liu L., Yan L., Donze J.R., Gerson S.L. Blockage of abasic site repair enhances antitumor efficacy of 1,3-bis-(2-chloroethyl)-1-nitrosourea in colon tumor xenografts. Mol. Cancer Ther. 2003, 2:1061-1066.
28. Lui R.C., Laregina M.C., Herbold D.R., Johnson F.E. Testicular cytotoxicity of intravenous doxorubicin in rats. J. Urol. 1986, 136:940-943.
29. 3, of red ginseng. Biol. Pharm. Bull. 1995, 18:1197-1202.
30. 2 on tumor growth in nude mice bearing human ovarian cancer cells. Jpn. J. Cancer Res. 1998, 98:733-740.
31. Park H.-J., Kim Y.-B., Kang T.-S., Jung I.-S., Kim K.-Y., Jeong H.-S. Immunomodulatory activities of oat bran extracts with different extraction conditions. Korean J. Food Sci. Technol. 2005, 37:103-107.
32. Popovich D.G., Kitts D.D. Structure-function relationship exists for ginsenosides in reducing cell proliferation and inducing apoptosis in the human leukemia (THP-1) cell line. Arch. Biochem. Biophys. 2002, 406:1-8.
33. Sakai H., Horinouchi H., Tomiyama K., Ikeda E., Takeoka S., Kobayashi K., Tsuchida E. Hemoglobin - vehicles as oxygen carriers. Influence of phagocytic activity and histopathological changes in reticuloendothelial system. Am. J. Pathol. 2001, 159:1079-1088.
34. Shin S., Jang J.Y., Park D., Yon J.-M., Baek I.-J., Hwang B.Y., Nam S.-Y., Yun Y.W., Kim K.-Y., Joo S.S., Kim Y.-B. Korean red ginseng extract does not cause embryo-fetal death or abnormalities in mice. Birth Defects Res. B: Dev. Reprod. Toxicol. 2010, 89:78-85.
35. Roh Y.W., Ji H.J., Chai H.-Y., Hwang S.-Y., Nam S.-Y., Hong J.T., Sung J.H., Kim H.-K., Kang H.-G., Kim Y.-B., Kang J.-K. Antitumor and cardioprotective effects of a ginseng intestinal metabolite in combination with doxorubicin in sarcoma-180 tumor-bearing mice. Korean J. Lab. Anim. Sci. 2004, 20:348-356.
36. Saha D., Roman C., Beauchamp R.D. New strategies for colorectal cancer prevention and treatment. World J. Surg. 2002, 26:762-766.
37. Seong Y.H., Shin C.S., Kim H.S., Baba A. Inhibitory effects of ginseng total saponins on glutamate-induced swelling of cultured astrocytes. Biol. Pharm. Bull. 1995, 18:1776-1778.
38. Takino Y. Studies on the pharmacodynamics of ginsenoside-Rg1, -Rb1 and -Rb2 in rats. Yakugaku Zasshi 1994, 114:550-564.
39. Tanaka O., Kasai R., Morita T. Chemistry of ginseng and related plants: recent advances. Abstr. Chin. Med. 1986, 1:130-152.
40. Tawab M.A., Bahr U., Karas M., Wurglics M., Schubert-Zsilavecz M. Degradation of ginsenosides in humans after oral administration. Drug Metab. Dispos. 2003, 31:1065-1071.
41. Wakabayashi C., Hasegawa H., Murata J., Saiki I. In vivo antimetastatic action of ginseng protopanaxadiol saponins is based on their intestinal bacterial metabolites after oral administration. Oncol. Res. 1997, 9:411-417.
42. Wang C.Z., Aung H.H., Ni M., Wu J.A., Tong R., Wicks S., He T.C., Yuan C.S. Red American ginseng: ginsenoside constituents and antiproliferative activities of heat-processed Panax quinquefolius roots. Planta Med. 2007, 73:669-674.
43. Wang C.Z., Zhang B., song W.X., Wang A., Ni M., Luo X., Aung H.H., Xie J.T., Tong R., He T.C., Yuan C.S. Steamed American ginseng berry: ginsenoside analyses and anticancer activities. J. Agric. Food Chem. 2006, 54:9936-9942.
44. Williams P.L., James R.C., Roberts S.M. Principles of Toxicology 2000, John Wiley & Sons, New York, pp. 209-217. second ed.
45. 3. Wei Sheng Wu Xue Bao 2008, 48:1181-1185.
46. Xu L.H., Deng C.S., Zhu Y.Q., Liu H.Q., Liu D.Z. Synergistic antitumor effect of TRAIL and doxorubicin on colon cancer cell line SW480. World J. Gastroenterol. 2003, 9:1241-1245.
47. 3 combined with cyclophosphamide on growth and angiogenesis of ovarian cancer. Chin. Med. J. 2007, 120:584-588.
48. Yang E.B., Tanhg W.Y., Zhang K., Cheng L.Y., Mack P.O.P. Norcantharidin inhibits growth of human Hep-G2 cell-transplanted tumor in nude mice and prolongs host survival. Cancer Lett. 1997, 117:93-98.
49. Yuan C.S., Wu J.A. Ginsenoside variability in American ginseng samples. Am. J. Clin. Nutr. 2002, 75:600-601.